Literature DB >> 25719275

Vascular Repair by Tissue-Resident Endothelial Progenitor Cells in Endotoxin-Induced Lung Injury.

Takeshi Kawasaki1, Tetsu Nishiwaki1, Ayumi Sekine1, Rintaro Nishimura1, Rika Suda1, Takashi Urushibara1, Toshio Suzuki1, Shin Takayanagi1, Jiro Terada1, Seiichiro Sakao1, Koichiro Tatsumi1.   

Abstract

Vascular disruption is one of the pathological hallmarks in acute respiratory distress syndrome. Bone marrow (BM)-derived circulating endothelial progenitor cells (EPCs) and lung tissue-resident EPCs have been considered to play a pivotal role in pulmonary vascular repair; however, which population is predominant in local pulmonary vasculogenesis remains to be clarified. We therefore examined the origin of EPCs participating in the regenerative process of pulmonary vascular endothelial cells (PVECs) in experimental acute respiratory distress syndrome. Lung samples from mice administered LPS intratracheally were investigated for cell dynamics and EPC functions. Quantitative flow cytometric analysis demonstrated that the number of PVECs decreased by roughly 20% on Day 1 and then recovered on Day 7 of LPS challenge. Bromodeoxyuridine-incorporation assays and immunofluorescence microscopy demonstrated that proliferating PVECs preferentially located in the capillary vessels. Experiments using BM chimera mice revealed that most of the regenerating PVECs were tissue-resident cells, and BM-derived cells hardly engrafted as PVECs. The population of circulating putative phenotypical EPCs decreased during the first week after LPS challenge. The regenerating PVECs were characterized by high colony-forming and vasculogenic capacities, intracellular reactive oxygen species scavenging and aldehyde dehydrogenase activites, and enhanced gene expression of Abcb1b (a drug-resistant gene), suggesting that the population of PVECs included tissue-resident EPCs activated during regenerative process of PVECs. The proliferating PVECs expressed CD34, Flk-1/KDR, and c-kit more strongly and Prom1/CD133 less strongly on the surface than nonproliferating PVECs. Our findings indicated that lung tissue-resident EPCs predominantly contribute to pulmonary vascular repair after endotoxin-induced injury.

Entities:  

Keywords:  LPS; acute respiratory distress syndrome; endothelial progenitor cells; endothelial repair; vascular regeneration

Mesh:

Substances:

Year:  2015        PMID: 25719275     DOI: 10.1165/rcmb.2014-0185OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

Review 1.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.

Authors:  Airan Liu; Xiwen Zhang; Hongli He; Li Zhou; Yoshifumi Naito; Shinji Sugita; Jae-Woo Lee
Journal:  Expert Opin Biol Ther       Date:  2019-11-18       Impact factor: 4.388

2.  Degradation of group V secretory phospholipase A2 in lung endothelium is mediated by autophagy.

Authors:  Lucille N Meliton; Xiangdong Zhu; Mary Brown; Yulia Epshtein; Takeshi Kawasaki; Eleftheria Letsiou; Steven M Dudek
Journal:  Microvasc Res       Date:  2019-11-13       Impact factor: 3.514

3.  A single-cell atlas of mouse lung development.

Authors:  Nicholas M Negretti; Erin J Plosa; John T Benjamin; Bryce A Schuler; A Christian Habermann; Christopher S Jetter; Peter Gulleman; Claire Bunn; Alice N Hackett; Meaghan Ransom; Chase J Taylor; David Nichols; Brittany K Matlock; Susan H Guttentag; Timothy S Blackwell; Nicholas E Banovich; Jonathan A Kropski; Jennifer M S Sucre
Journal:  Development       Date:  2021-12-20       Impact factor: 6.868

4.  Flow-cytometric method for simultaneous analysis of mouse lung epithelial, endothelial, and hematopoietic lineage cells.

Authors:  Benjamin D Singer; Jason R Mock; Franco R D'Alessio; Neil R Aggarwal; Pooja Mandke; Laura Johnston; Mahendra Damarla
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-04       Impact factor: 5.464

5.  XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.

Authors:  Mahendra Damarla; Laura F Johnston; Gigi Liu; Li Gao; Lan Wang; Lidenys Varela; Todd M Kolb; Bo S Kim; Rachel L Damico; Paul M Hassoun
Journal:  Physiol Rep       Date:  2017-08

6.  Endothelial Cdc42 deficiency impairs endothelial regeneration and vascular repair after inflammatory vascular injury.

Authors:  Jiawen Lv; Junchao Zeng; Fukun Guo; Yiran Li; Mengying Xu; Yuanxiong Cheng; Lin Zhang; Shaoxi Cai; Yinghua Chen; Yi Zheng; Guodong Hu
Journal:  Respir Res       Date:  2018-02-08

7.  Endothelial progenitor cells in chronic obstructive pulmonary disease and emphysema.

Authors:  Margaret F Doyle; Russell P Tracy; Megha A Parikh; Eric A Hoffman; Daichi Shimbo; John H M Austin; Benjamin M Smith; Katja Hueper; Jens Vogel-Claussen; Joao Lima; Antoinette Gomes; Karol Watson; Steven Kawut; R Graham Barr
Journal:  PLoS One       Date:  2017-03-14       Impact factor: 3.240

8.  Endothelial stem and progenitor cells (stem cells): (2017 Grover Conference Series).

Authors:  Mervin C Yoder
Journal:  Pulm Circ       Date:  2017-11-03       Impact factor: 3.017

Review 9.  Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension.

Authors:  France Dierick; Julien Solinc; Juliette Bignard; Florent Soubrier; Sophie Nadaud
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

Review 10.  Endothelial Progenitor Cells in Moyamoya Disease: Current Situation and Controversial Issues.

Authors:  Jin Yu; Qian Du; Miao Hu; Jianjian Zhang; Jincao Chen
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.